80 Followers on Owler
OverviewCompetitorsFundingNews & Insights

aTyr Pharma Competitors or Alternatives

aTyr Pharma's top competitors include Ventyx, Evommune and Qu Biologics.

Unlock 17 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

aTyr Pharma's company profile

Sanjay S. Shukla

President & CEO

82/100
53
$430.1M
$ < 1M
  • $430.1M
    $ < 1M
  • 53
    $430.1M
  • $ < 1M
  • 82/100
  • 53
  • $430.1M
  • $ < 1M
View ProfileView
1
aTyr Pharma's Competitor - Ventyx logo

Raju Mohan

Founder & CEO

90/100
30
$520.5M
  • $520.5M
  • 30
    $520.5M
  • 90/100
  • 30
  • $520.5M
View ProfileView
2
aTyr Pharma's Competitor - Evommune logo

Luis Pena

President & CEO

90/100
25 - 100
$268M
$100K - 5M
  • $268M
    $100K - 5M
  • 25 - 100
    $268M
  • $100K - 5M
  • 90/100
  • 25 - 100
  • $268M
  • $100K - 5M
View ProfileView
3
aTyr Pharma's Competitor - Qu Biologics logo

Hal Gunn

Founder & CEO

88/100
25 - 100
$41.4M
$100K - 5M
  • $41.4M
    $100K - 5M
  • 25 - 100
    $41.4M
  • $100K - 5M
  • 88/100
  • 25 - 100
  • $41.4M
  • $100K - 5M
View ProfileView
4
aTyr Pharma's Competitor - NexImmune logo

Kristi Jones

CEO

86/100
6
$166.4M
  • $166.4M
  • 6
    $166.4M
  • 86/100
  • 6
  • $166.4M
View ProfileView
5
aTyr Pharma's Competitor - Agenus logo

Garo H. Armen

Chairman & CEO

85/100
440
$352.2M
$103.5M
  • $352.2M
    $103.5M
  • 440
    $352.2M
  • $103.5M
  • 85/100
  • 440
  • $352.2M
  • $103.5M
View ProfileView
aTyr Pharma's top 20 competitors are Ventyx, Evommune, Qu Biologics, Ultragenyx, NexImmune, Agenus, Kite Pharma, Bristol-Myers Squibb, Novartis, Clementia Pharmaceuticals, Inc., Inovio, Juno Therapeutics, bluebird bio, Gilead, Aura, NGM Bio, OncoMed Pharmaceuticals, Sutro Biopharma, Centrose and InterMune. Together they have raised over 38.1B between their estimated 133.6K employees. aTyr Pharma has 53 employees and is ranked 13th among it's top 10 competitors. The top 10 competitors average 6,366.

aTyr Pharma VS Ventyx

Ventyx is one of aTyr Pharma's top rivals. Ventyx was founded in San Diego, California} in 2018. Like aTyr Pharma, Ventyx also competes in the Biotechnology space. Compared to aTyr Pharma, Ventyx generates $ less revenue.

aTyr Pharma VS Evommune

Evommune is aTyr Pharma's #2 competitor. Evommune was founded in 2020, and is headquartered in Palo Alto, California. Like aTyr Pharma, Evommune also operates in the Biotechnology space. Evommune generates $1.5M more revenue vs. aTyr Pharma.

aTyr Pharma VS Qu Biologics

Qu Biologics is a top competitor of aTyr Pharma. Qu Biologics's headquarters is in Burnaby, British Columbia, and was founded in 2007. Like aTyr Pharma, Qu Biologics also works within the Biotechnology sector. Qu Biologics generates 468% of aTyr Pharma's revenue.

Looking for similar companies to aTyr Pharma?

Similar Companies

Biotechnology companies in San Diego

See 553 companies 
Pharmaceuticals & Biotechnology companies in San Diego

See 720 companies 
Biotechnology companies in San Diego County

See 687 companies 
Pharmaceuticals & Biotechnology companies in San Diego County

See 904 companies 
Biotechnology companies in California

See 3,097 companies 
Pharmaceuticals & Biotechnology companies in California

See 4,181 companies 
Biotechnology companies with revenue in $100K-5.0M range

See 4,537 companies 
Biotechnology companies with employees in 25-100 range

See 5,165 companies 
Pharmaceuticals & Biotechnology companies with revenue in $100K-5.0M range

See 6,045 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for aTyr Pharma and aTyr Pharma's Competitors

April 11, 2025Beckers Hospital Review
Novartis plans to invest $23 billion over the next five years to expand its manufacturing and research in the U.S. The investment will cover more than...
April 10, 2025Marketscreener
At Gilead, putting people first is central to all we do. That's why we're proud to be recognized as a responsible company by patient advocacy groups re...
April 10, 2025Pharmabiz
Bristol Myers Squibb, announced that the US Food and Drug Administration (FDA) approved Opdivo (nivolumab) plus Yervoy (ipilimumab) as a first─line tre...
April 11, 2025BioSpace
Novartis plans to build seven new facilities in the U.S., touting the creation of up to 1,000 new jobs at the company. The new facilities will include ...
April 10, 2025Pharmaceutical Processing World
Novartis announced today that it plans to invest $23 billion over five years to expand its U.S.-based infrastructure. The company said its investment a...
April 11, 2025SupplyChain247
Novartis will invest $23 billion over five years to expand its U.S. manufacturing operations, including a $1.1 billion research hub in San Diego....
April 10, 2025Openpr
The Global cGAS STING Pathway Market is estimated to be valued at USD 0.71 Billion in 2024 and is expected to reach USD 3.41 Billion by 2031, growing a...
April 10, 2025Openpr
Newest qualitative research report on the Cancer Cell Market 2025, published by Coherent Market Insights, offers in-depth insights into regional and gl...

Frequently Asked Questions about aTyr Pharma

  1. Who are aTyr Pharma's top competitors?

    aTyr Pharma's top 3 competitors are Ventyx, Evommune, Qu Biologics.

  2. Who is similar to aTyr Pharma?

    Ventyx is the most similar to aTyr Pharma. Evommune and Qu Biologics are also similar to aTyr Pharma.

  1. Are aTyr Pharma and Ventyx competitors?

    Yes, Ventyx is one of aTyr Pharma’s top competitors.